thefederalregister.org Federal Register Research Archive

Document

Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals Inc.

Department of Justice Drug Enforcement Administration [Docket No. DEA-566] ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic classes, and...

PDF versionSource Record
Department of Justice
Drug Enforcement Administration
  1. [Docket No. DEA-566]

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 25, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on October 9, 2019, Janssen Pharmaceuticals Inc., Buildings 1-5 & 7-14, 1440 Olympic Drive, Athens, Georgia 30601 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substance Drug code Schedule
Methylphenidate 1724 II
Hydromorphone 9150 II
Hydrocodone 9193 II
Oripavine 9330 II
Thebaine 9333 II
Tapentadol 9780 II

The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.

Dated: December 10, 2019.

William T. McDermott,

Assistant Administrator.

[FR Doc. 2019-27952 Filed 12-26-19; 8:45 am]

BILLING CODE 4410-09-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

84 FR 71474

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals Inc.,” thefederalregister.org (December 27, 2019), https://thefederalregister.org/documents/2019-27952/bulk-manufacturer-of-controlled-substances-application-janssen-pharmaceuticals-inc.